News
RBGLY
13.93
-0.85%
-0.12
Reckitt Benckiser upgraded to Overweight from Neutral at JPMorgan
TipRanks · 2h ago
Positive Report for Reckitt (RKT) from J.P. Morgan
TipRanks · 3h ago
Reckitt Legal Overhang Clears as Bellwether Win Supports Unchanged Buy Rating and $6100 Price Target
TipRanks · 3h ago
Barclays Sticks to Their Buy Rating for Reckitt (RKT)
TipRanks · 4h ago
Weekly Report: what happened at RBGLY last week (0824-0828)?
Weekly Report · 1d ago
David Hayes Lifts Reckitt Price Target to $6,100 on Strong Underlying Growth and Diminishing Litigation Risks
TipRanks · 6d ago
Weekly Report: what happened at RBGLY last week (0817-0821)?
Weekly Report · 08/24 09:28
Buy Rating Reaffirmed on Litigation Progress, Price Target Maintained at $5900
TipRanks · 08/21 09:55
Weekly Report: what happened at RBGLY last week (0810-0814)?
Weekly Report · 08/17 09:28
Weekly Report: what happened at RBGLY last week (0803-0807)?
Weekly Report · 08/10 09:26
Reckitt Benckiser: Core Brands Remain Undervalued Despite Mead Johnson Litigation Risk
Seeking Alpha · 08/07 05:34
Berenberg Bank Sticks to Its Hold Rating for Reckitt Benckiser Group (RBGLY)
TipRanks · 08/06 05:55
Reckitt (RKT) Receives a Hold from Berenberg Bank
TipRanks · 08/05 09:05
Reckitt (RKT) Receives a Buy from Barclays
TipRanks · 08/04 06:46
Weekly Report: what happened at RBGLY last week (0727-0731)?
Weekly Report · 08/03 09:26
Goldman Sachs Sticks to Its Hold Rating for Reckitt (RKT)
TipRanks · 07/31 05:56
Deutsche Bank Sticks to Their Hold Rating for Reckitt (RKT)
TipRanks · 07/30 17:05
Reckitt Benckiser Group: A Solid Quarter Supports The Investment Case
Seeking Alpha · 07/30 09:17
UBS Remains a Buy on Reckitt (RKT)
TipRanks · 07/30 08:47
RBC Capital Reaffirms Their Hold Rating on Reckitt (RKT)
TipRanks · 07/30 07:25
More
Webull provides a variety of real-time RBGLY stock news. You can receive the latest news about Reckitt Benckiser Group PLC through multiple platforms. This information may help you make smarter investment decisions.
About RBGLY
Reckitt Benckiser Group PLC (Reckitt) is a United Kingdom-based global consumer brands company. The Company's operating segments comprise Core Emerging Markets, Core Europe, Core North America, Mead Johnson Nutrition and Vestacy Transitional Service. Its self-care products include Strepsils, Mucinex, Gaviscon and Nurofen and provide over-the-counter treatments. Its Lysol, Dettol and Harpic protect against the spread of germs and drive adoption of hygienic habits. Its household care products include Finish and Vanish, which are cleaning solutions. Its intimate wellness products include Durex and Veet. Its brand Strepsils is a sore throat medicine. Gaviscon is a heartburn and indigestion relief provider. Mead Johnson Nutrition (MJN) provides infant and pediatric nutrition. Its subsidiaries include Mead Johnson Nutrition (Thailand) Ltd, Access VC Limited, Durex Limited, Reckitt Benckiser Healthcare Australia Pty Limited, and others.